Stock analysts at StockNews.com assumed coverage on shares of SenesTech (NASDAQ:SNES – Get Free Report) in a research report issued on Friday. The firm set a “sell” rating on the stock.
Separately, HC Wainwright upped their price objective on shares of SenesTech from $3.50 to $10.00 and gave the company a “buy” rating in a research note on Thursday, December 12th.
View Our Latest Stock Report on SenesTech
SenesTech Stock Up 0.6 %
SenesTech Company Profile
SenesTech, Inc develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.
Further Reading
- Five stocks we like better than SenesTech
- How to Invest in Small Cap StocksĀ
- Top 3 Investment Themes to Watch for in 2025
- Insider Buying Explained: What Investors Need to Know
- Mega Buybacks in 2025: Why These 3 Leading Stocks Are Buys
- What Investors Need to Know to Beat the Market
- AMD vs. NVIDIA: The Better Semiconductor Bet for 2025
Receive News & Ratings for SenesTech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SenesTech and related companies with MarketBeat.com's FREE daily email newsletter.